Promoting Treatment Engagement with Specific Populations: Depression
| Autor: | Amy E. Naugle, Marie C. Barrett, Laura E. Stayton |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
business.industry Lifetime prevalence Disease Placebo medicine.disease World health Treatment engagement 030227 psychiatry 03 medical and health sciences 0302 clinical medicine Epidemiology medicine Major depressive disorder 030212 general & internal medicine business Psychiatry Depression (differential diagnoses) |
| Zdroj: | Practical Strategies and Tools to Promote Treatment Engagement ISBN: 9783319492049 |
| DOI: | 10.1007/978-3-319-49206-3_10 |
| Popis: | Depressive disorders were identified as a leading cause of burden in the Global Burden of Disease studies conducted in 1990, 2000, and 2010. In the 2010 study, major depressive disorder (MDD) was identified as a contributor of burden allocated to both suicide and ischemic heart disease (Ferrari et al., 2013). The World Health Organization (WHO) ranks MDD as the fourth leading cause of disability worldwide and predicts that by 2020, MDD will be the second leading cause of disability. Data on the prevalence and costs of depressive disorders worldwide are limited, but existing studies suggest that lifetime prevalence rates are between 1.5 % and 19 %, with higher rates occurring in higher income countries. Epidemiological studies have identified costs related to depression that impact living in four domains: education, marital timing and stability, childbearing, and occupation (Kessler, 2012). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|